Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
3
×
clinical trials
3
×
life sciences
national blog main
national top stories
new york blog main
blackstone group
david goldstein
depression
epilepsy
essential tremor
kiran reddy
major depressive disorder
new york top stories
perimenopausal depression
praxis precision medicines
startups
steven petrou
third rock ventures
adeno-associated virus
aligos therapeutics
antisense oligonucleotide
baker brothers life sciences
benzodiazepine
benzodiazepines
biogen
biotech ipos
blackstone life sciences
blepharitis
cancer
cavion
cephalgia
chemotherapy
chronic hepatitis b virus
cisplatin
columbia university
decibel therapeutics
What
drugs
3
×
medicines
3
×
emerged
praxis
precision
research
adding
ago
aiming
aims
backed
balance
biotechs
build
cause
central
ceo
cns
decibel
disorder
epilepsy
focus
forms
genes
genetic
hearing
ipos
kept
leads
links
loss
marcio
med
mutations
nervous
neuro
new
pipeline
prep
quiet
Language
unset
Current search:
drugs
×
medicines
×
" clinical trials "
×
" boston top stories "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus